Download PDF
Pharmacopsychiatry 2001; 34(Suppl1): 74-82
DOI: 10.1055/s-2001-15510
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Modulation of Ion Channels in Rat Neurons by the Constituents of Hypericum Perforatum

O. Krishtal1 , N. Lozovaya1 , A. Fisunov1 , T. Tsintsadze1 , Y. Pankratov1 , M. Kopanitsa1 , S. S. Chatterjee2
  • 1Bogomoletz Institute of Physiology, Kiev, Ukraine
  • 2Dr. Willmar Schwabe GmbH & Co., Karlsruhe, Germany
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Despite almost forty years of widespread use of antidepressant drugs, their mode of action is still unknown. Hyperforin, a phloroglucinol derivative, is a major pharmacologically and therapeutically active constituent of Hypericum perforatum extract that is widely used as an herbal antidepressant drug. However, the mechanism or mechanisms of action of these naturally abundant, non-toxic extracts remain unclear. Enzymatically isolated patch-clamped rat central and peripheral neurons exposed to rapid changes in the composition of external medium (concentration clamp) were used in our experiments to investigate the modulation of the various voltage- and ligand-gated channels by hyperforin, as well as by other constituents of Hypericum perforatum. At nanomolar concentrations, hyperforin induced significant inhibition of various ion channels. In the case of P-type Ca2+ channels, we established that hyperforin acts via interaction with calmodulin or through calmodulin-activated pathways involving at least one second messenger. The results presented here indicate that multiple mechanisms and extract constituents may be involved in the antidepressant action of Hypericum extracts, and that they could also possess neuroprotective and analgesic effects.

References

  • 1 Arborelius L, Owens M J, Plotsky P M, C. B. Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J.  Endocrinol.. 1999;  160 1-12
    CrossrefPubMedGoogle Scholar
  • 2 Barritt G J, Gregory R B. An evaluation of strategies available for the identification of GTP-binding proteins required in intracellular signalling pathways.  Cell Signal. 1997;  9 207-218
    CrossrefPubMedGoogle Scholar
  • 3 Bean B P. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence.  Nature. 1989;  340 153-156
    CrossrefPubMedGoogle Scholar
  • 4 Brorson J R, Manzolillo P A, Gibbons S J, Miller R J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity.  J Neurosci. 1995;  15 4515-4524
    PubMedGoogle Scholar
  • 5 Brorson J R, Manzolillo P A,. Miller RJ. Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells.  J Neurosci. 1994;  14 187-197
    PubMedGoogle Scholar
  • 6 Burnstock G. A unifying purinergic hypothesis for the initiation of pain.  Lancet. 1996;  347 1604-1605
    CrossrefPubMedGoogle Scholar
  • 7 Carter A J. The importance of voltage-dependent sodium channels in cerebral ischaemia.  Amino Acids. 1998;  14 159-169
    CrossrefPubMedGoogle Scholar
  • 8 Chatterjee S, Filippov V, Lishko P, Maximyuk O, Noldner M, Krishtal O. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat.  Life Sci. 1999;  65 2395-2405
    CrossrefPubMedGoogle Scholar
  • 9 Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Muller W E. Hyperforin as a possible antidepressant component of Hypericum extracts.  Life Sci. 1998a;  63 499-510
    CrossrefPubMedGoogle Scholar
  • 10 Chatterjee S S, Noldner M, Koch E, Erdelmeier C. Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility.  Pharmacopsychiatry.. 1998b;  31 ((Suppl. 1)) 7-15
    PubMedGoogle Scholar
  • 11 Chizhmakov I V, Kiskin N I, Krishtal O A. Two types of steady-state desensitization of N-methyl-D-aspartate receptor in isolated hippocampal neurones of rat.  J Physiol (Lond.). 1992;  448 453-472
    PubMedGoogle Scholar
  • 12 Choi D W. Excitotoxic cell death.  J Neurobiol. 1992;  23 1261-1276
    CrossrefPubMedGoogle Scholar
  • 13 Choi D W. Calcium: still center-stage in hypoxic-ischemic neuronal death.  Trends Neurosci. 1995;  18 58-60
    CrossrefPubMedGoogle Scholar
  • 14 Ding Y, Cesare P, Drew L, Nikitaki D, Wood J N. ATP, P2X receptors and pain pathways.  J Auton Nerv Syst. 2000;  81 289-294
    CrossrefPubMedGoogle Scholar
  • 15 Doble A. Excitatory amino acid receptors and neurodegeneration.  Therapie. 1995;  50 319-337
    PubMedGoogle Scholar
  • 16 el-Mallakh R S. The Na,K-ATPase hypothesis for manic-depression. II. The mechanism of action of lithium.  Med Hypotheses. 1983;  12 269-282
    PubMedGoogle Scholar
  • 17 Elmslie K S, Zhou W, Jones S W. LHRH and GTP-gamma-S modify calcium current activation in bullfrog sympathetic neurons.  Neuron. 1990;  5 75-80
    CrossrefPubMedGoogle Scholar
  • 18 Evans R J, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A, North R A. Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells.  J Physiol (Lond). 1996;  497 413-422
    PubMedGoogle Scholar
  • 19 Fisunov A, Lozovaya N, Tsintsadze T, Chatterjee S, Noldner M, Krishtal O. Hyperforin modulates gating of P-type Ca2+ current in cerebellar Purkinje neurons.  Pflugers Arch. 2000;  440 427-434
    PubMedGoogle Scholar
  • 20 Grassi F, Lux H D. Voltage-dependent GABA-induced modulation of calcium currents in chick sensory neurons.  Neurosci Lett. 1989;  105 113-119
    CrossrefPubMedGoogle Scholar
  • 21 Iino M, Ozawa S, Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones.  J Physiol (Lond). 1990;  424 151-165
    PubMedGoogle Scholar
  • 22 James P, Vorherr T, Carafoli E. Calmodulin-binding domains: just two faced or multi-faceted?.  Trends Biochem Sci. 1995;  20 38-42
    CrossrefPubMedGoogle Scholar
  • 23 Jurado L A, Chockalingam P S, Jarrett H W. Apocalmodulin.  Physiol Rev. 1999;  79 661-682
    PubMedGoogle Scholar
  • 24 Kasai H, Aosaki T. Modulation of Ca-channel current by an adenosine analog mediated by a GTP-binding protein in chick sensory neurons.  Pflugers Arch. 1989;  414 145-149
    PubMedGoogle Scholar
  • 25 Kopanitsa M V, Panchenko V A, Magura E I, Lishko P V, Krishtal O A. Capsaicin blocks Ca2+ channels in isolated rat trigeminal and hippocampal neurones.  Neuroreport. 1995;  6 2338-2340
    PubMedGoogle Scholar
  • 26 Lee A, Wong S T, Gallagher D, Li B, Storm D R, Scheuer T, Catterall W A. Ca2+/calmodulin binds to and modulates P/Q-type calcium channels.  Nature. 1999;  399 155-159
    CrossrefPubMedGoogle Scholar
  • 27 Lin C T, Dedman J R, Brinkley BR,Means A R. Localization of calmodulin in rat cerebellum by immunoelectron microscopy.  J Cell Biol. 1980;  85 473-480
    CrossrefPubMedGoogle Scholar
  • 28 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St John’s wort for depression - an overview and meta-analysis of randomised clinical trials.  BMJ. 1996;  313 253-258
    PubMedGoogle Scholar
  • 29 Maubach K A, Rupniak N M, Kramer M S, Hill R G. Novel strategies for pharmacotherapy of depression.  Curr Opin Chem Biol. 1999;  3 481-488
    CrossrefPubMedGoogle Scholar
  • 30 McEwen B S, Sapolsky R M. Stress and cognitive function.  Curr Opin Neurobiol. 1995;  5 205-216
    CrossrefPubMedGoogle Scholar
  • 31 Means A R, VanBerkum M F, Bagchi I, Lu K P, Rasmussen C D. Regulatory functions of calmodulin.  Pharmacol Ther. 1991;  50 255-270
    CrossrefPubMedGoogle Scholar
  • 32 Mintz I M, Bean B P. GABAB receptor inhibition of P-type Ca2+ channels in central neurons.  Neuron. 1993;  10 889-898
    CrossrefPubMedGoogle Scholar
  • 33 Mintz I M, Venema M J, Swiderek K M, Lee T D, Bean B P, Adams M E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA.  Nature. 1992;  355 827-829
    CrossrefPubMedGoogle Scholar
  • 34 Müller W E, Singer A, Wonneman M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract.  Pharmacopsychiatry. 1998;  31 ((Suppl. 1)) 16-21
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L.  Pharmacopsychiatry. 1997;  30 ((Suppl. 2)) 129-134
    PubMedGoogle Scholar
  • 36 Nixon R A, Saito K I, Grynspan F, Griffin W R, Katayama S, Honda T, Mohan P S, Shea T B, Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer’s disease.  Ann N Y Acad Sci. 1994;  74 77-91
    PubMedGoogle Scholar
  • 37 Ortolano G A, Swonger A K, Kaiser E A, Hammond R P. A calcium hypothesis of antidepressant action.  Med Hypotheses. 1983;  10 207-221
    PubMedGoogle Scholar
  • 38 Panchenko V A, Krishtal O A, Tegtmeier F, Tsyndrenko A Y. R56865 as Ca2+-channel blocker in Purkinje neurons of rat: comparison with flunarizine and nimodipine.  Neuroscience. 1993;  54 587-594
    CrossrefPubMedGoogle Scholar
  • 39 Patel S, Morris S A, Adkins C E, O’Beirne G, Taylor C W. Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization.  Proc Natl Acad Sci USA. 1997;  94 11 627-11 632
    PubMedGoogle Scholar
  • 40 Regan L J. Voltage-dependent calcium currents in Purkinje cells from rat cerebellar vermis.  J Neurosci. 1991;  11 2259-2269
    PubMedGoogle Scholar
  • 41 Scolnick P. Antidepressants for the new millenium.  Eur J Pharmacol. 1999;  375 31-40
    CrossrefPubMedGoogle Scholar
  • 42 Siggins G R, Gruol D, Aldenhoff J, Pittman Q. Electrophysiological actions of corticotropin-releasing factor in the central nervous system.  Fed Proc. 1985;  44 237-242
    PubMedGoogle Scholar
  • 43 Sprang S R. G protein mechanisms: insights from structural analysis.  Annu Rev Biochem. 1997;  66 639-678
    CrossrefPubMedGoogle Scholar
  • 44 Urenjak J, Obrenovitch T P. Pharmacological modulation of voltage-gated Na+ channels: a rational and effective strategy against ischemic brain damage.  Pharmacol Rev. 1996;  48 21-67
    PubMedGoogle Scholar
  • 45 Virginio C, North R A, Surprenant A. Calcium permeability and block at homomeric and heteromeric P2X2 and P2X3 receptors, and P2X receptors in rat nodose neurones.  J Physiol (Lond). 1998;  510 27-35
    CrossrefPubMedGoogle Scholar
  • 46 Vogel H J. The Merck Frosst Award Lecture 1994. Calmodulin: a versatile calcium mediator protein.  Biochem Cell Biol. 1994;  72 357-376
    PubMedGoogle Scholar
  • 47 Weiss J H, Sensi S L. Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration.  Trends Neurosci. 2000;  23 365-371
    CrossrefPubMedGoogle Scholar
  • 48 Yamaki T, Hidaka H. Ca2+-independent stimulation of cyclic GMP-dependent protein kinase by calmodulin.  Biochem Biophys Res Commun. 1980;  94 727-733
    CrossrefPubMedGoogle Scholar
  • 49 Yuan T, Vogel H J, Sutherland C, Walsh M P. Characterization of the Ca2+ -dependent and -independent interactions between calmodulin and its binding domain of inducible nitric oxide synthase.  FEBS Lett. 1998;  431 210-214
    CrossrefPubMedGoogle Scholar
  • 50 Yuan T, Walsh M P, Sutherland C, Fabian H, Vogel H J. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.  Biochemistry. 1999;  38 1446-1455
    CrossrefPubMedGoogle Scholar

Dr. O. Krishtal,MD 

Department of Cellular Membranology
Bogomoletz Institute of Physiology

4 Bogomoletz Street

Kiev 01024

Ukraine

Fax: +380 44 2562590

Email: krishtal@serv.biph.kiev.ua

      >